Search

Your search keyword '"Brunetto, Maurizia R."' showing total 28 results

Search Constraints

Start Over You searched for: Author "Brunetto, Maurizia R." Remove constraint Author: "Brunetto, Maurizia R." Publisher elsevier bv Remove constraint Publisher: elsevier bv
28 results on '"Brunetto, Maurizia R."'

Search Results

1. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

2. Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort

3. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

5. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

6. Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment

7. Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants

8. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

9. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

10. Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals

11. Steato-Score: Non-Invasive Quantitative Assessment of Liver Fat by Ultrasound Imaging

12. RETRACTION: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients with Chronic HBV Infection

13. TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues

14. Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up

15. New immunoassays for total, IgA and IgM antibodies against hepatitis E virus: Prevalence in Italian blood donors and patients with chronic liver or kidney diseases

18. Daclatasvir Plus Peginterferon and Ribavirin Is Noninferior to Peginterferon and Ribavirin Alone, and Reduces the Duration of Treatment for HCV Genotype 2 or 3 Infection

19. Triple therapy with first-generation Protease Inhibitors for patients with genotype 1 chronic hepatitis C: Recommendations of the Italian Association for the Study of the Liver (AISF)

21. Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a

22. Statements from the Taormina expert meeting on occult hepatitis B virus infection

25. High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: identification of G4 isolates in Italy

26. T-lymphocyte response to hepatitis C virus in different clinical courses of infection

27. Sequence variation in hepatitis C viral isolates

28. Serum markers of hepatitis B virus replication, liver histology and intrahepatic expression of hepatitis B core antigen

Catalog

Books, media, physical & digital resources